Annual Park City Update

Program Schedule

Sunday, February 9
4:30-5:30pm
Susan C. Lester, MD, PhD

Susan C. Lester, MD, PhD

Senior Consultant, Brigham and Women's Hospital, Department of Pathology and Dana Farber Cancer Institute
Assistant Professor of Pathology, Harvard Medical School

Dr. Lester received her PhD in genetics at the University of Wisconsin and her MD from Harvard Medical School. She trained in pathology at Brigham and Women’s Hospital in Boston and was the Chief of Breast Pathology Services for over 20 years. She has served on committees for the College of American Pathology, the American Joint Committee on Cancer, and the World Health Organization. She was the chairperson of the CAP breast cancer review panel during the development of the first standardized reporting protocol for DCIS as well as a major revision of the invasive cancer protocol. Dr. Lester is well known for writing the Manual of Surgical Pathology, as well as co-writing Diagnostic Pathology: Breast with Dr. David Hicks, and being the lead writer of Diagnostic Pathology: Intraoperative Consultation (both included in ExpertPath and PathPrimer). She has also written numerous chapters including the Breast Chapter for Robbins and Cotran Pathologic Basis of Disease and Robbins Basic Pathology. She has a major interest in pathologic/radiologic correlation and has published widely in this area. A current area of interest is developing open access internet pathology teaching education tailored for pathologists in countries with limited resources.

Inflammatory Lesions of the Breast and the Role of the Breast Microbiome
5:30-6:30pm
H. Evin Gulbahce, MD

H. Evin Gulbahce, MD

Professor of Pathology, University of Utah School of Medicine
Medical Director, Surgical Pathology and Oncology, ARUP Laboratories

Dr. Gulbahce is a professor of pathology at the University of Utah School of Medicine. She received her MD from Hacettepe University in Ankara, Turkey, and completed a residency in anatomic and clinical pathology and a surgical pathology fellowship at the University of Minnesota. Dr. Gulbahce has received the Clinical Excellence and Outstanding Teaching awards from the Department of Pathology, University of Utah School of Medicine. Her research interests include breast Cancer risk factors, specifically for basal-like and triple negative breast cancers and HER2 testing.

Papillary Lesions of the Breast
6:30-7:30pm
Susan C. Lester, MD, PhD

Susan C. Lester, MD, PhD

Senior Consultant, Brigham and Women's Hospital, Department of Pathology and Dana Farber Cancer Institute
Assistant Professor of Pathology, Harvard Medical School

Dr. Lester received her PhD in genetics at the University of Wisconsin and her MD from Harvard Medical School. She trained in pathology at Brigham and Women’s Hospital in Boston and was the Chief of Breast Pathology Services for over 20 years. She has served on committees for the College of American Pathology, the American Joint Committee on Cancer, and the World Health Organization. She was the chairperson of the CAP breast cancer review panel during the development of the first standardized reporting protocol for DCIS as well as a major revision of the invasive cancer protocol. Dr. Lester is well known for writing the Manual of Surgical Pathology, as well as co-writing Diagnostic Pathology: Breast with Dr. David Hicks, and being the lead writer of Diagnostic Pathology: Intraoperative Consultation (both included in ExpertPath and PathPrimer). She has also written numerous chapters including the Breast Chapter for Robbins and Cotran Pathologic Basis of Disease and Robbins Basic Pathology. She has a major interest in pathologic/radiologic correlation and has published widely in this area. A current area of interest is developing open access internet pathology teaching education tailored for pathologists in countries with limited resources.

Evaluation of Breast Cancer After Neoadjuvant Therapy
Monday, February 10
7:00-8:00am
Adam L. Cohen, MD, MS

Adam L. Cohen, MD, MS

Associate Professor of Oncology, University of Utah School of Medicine

Dr. Cohen is an associate professor in the University of Utah's Division of Oncology in the Department of Medicine. He is a Huntsman Cancer Institute (HCI) investigator and a member of the Experimental Therapeutics program. He is also the vice chair of HCI PRMC. His specialties are neuro-oncology, breast oncology and gynecologic cancers.

Dr. Cohen's research focuses on clinical trials with the goal of personalizing treatment decisions for brain and breast cancer. He uses large sets of data to study gene expression patterns related to therapy response. He also helps scientists at HCI and the University of Utah translate their lab findings into clinical trials.

He has been at the University of Utah since 2009. Cohen completed a hematology/oncology fellowship at HCI and served as chief fellow. Before HCI, Dr. Cohen was chief resident in the Department of Internal Medicine at Banner Good Samaritan Medical Center in Phoenix, Arizona. He received his medical degree from Harvard Medical School. He received his undergraduate degree from Harvard College and a Master's in Mathematics from University of Chicago.

Application of Advances in Molecular Testing in the Clinical Management of Breast Cancer Patients
8:00-9:00am
Susan C. Lester, MD, PhD

Susan C. Lester, MD, PhD

Senior Consultant, Brigham and Women's Hospital, Department of Pathology and Dana Farber Cancer Institute
Assistant Professor of Pathology, Harvard Medical School

Dr. Lester received her PhD in genetics at the University of Wisconsin and her MD from Harvard Medical School. She trained in pathology at Brigham and Women’s Hospital in Boston and was the Chief of Breast Pathology Services for over 20 years. She has served on committees for the College of American Pathology, the American Joint Committee on Cancer, and the World Health Organization. She was the chairperson of the CAP breast cancer review panel during the development of the first standardized reporting protocol for DCIS as well as a major revision of the invasive cancer protocol. Dr. Lester is well known for writing the Manual of Surgical Pathology, as well as co-writing Diagnostic Pathology: Breast with Dr. David Hicks, and being the lead writer of Diagnostic Pathology: Intraoperative Consultation (both included in ExpertPath and PathPrimer). She has also written numerous chapters including the Breast Chapter for Robbins and Cotran Pathologic Basis of Disease and Robbins Basic Pathology. She has a major interest in pathologic/radiologic correlation and has published widely in this area. A current area of interest is developing open access internet pathology teaching education tailored for pathologists in countries with limited resources.

Spindle Cell Lesions of the Breast
4:30-5:30pm
Susan C. Lester, MD, PhD

Susan C. Lester, MD, PhD

Senior Consultant, Brigham and Women's Hospital, Department of Pathology and Dana Farber Cancer Institute
Assistant Professor of Pathology, Harvard Medical School

Dr. Lester received her PhD in genetics at the University of Wisconsin and her MD from Harvard Medical School. She trained in pathology at Brigham and Women’s Hospital in Boston and was the Chief of Breast Pathology Services for over 20 years. She has served on committees for the College of American Pathology, the American Joint Committee on Cancer, and the World Health Organization. She was the chairperson of the CAP breast cancer review panel during the development of the first standardized reporting protocol for DCIS as well as a major revision of the invasive cancer protocol. Dr. Lester is well known for writing the Manual of Surgical Pathology, as well as co-writing Diagnostic Pathology: Breast with Dr. David Hicks, and being the lead writer of Diagnostic Pathology: Intraoperative Consultation (both included in ExpertPath and PathPrimer). She has also written numerous chapters including the Breast Chapter for Robbins and Cotran Pathologic Basis of Disease and Robbins Basic Pathology. She has a major interest in pathologic/radiologic correlation and has published widely in this area. A current area of interest is developing open access internet pathology teaching education tailored for pathologists in countries with limited resources.

Common Errors in Breast Pathology and How to Avoid Them
5:30-6:30pm
Rachel E. Factor, MD, MHS

Rachel E. Factor, MD, MHS

Associate Professor of Surgical Pathology and Cytopathology, University of Utah School of Medicine
Medical Director, Anatomic Pathology and Cytopathology, ARUP Laboratories

Dr. Factor is an associate professor of surgical pathology and cytopathology at the University of Utah and a medical director at ARUP Laboratories. She is the Director of breast pathology and the Co-Director of the cytology fellowship program. Factor is a Huntsman Cancer Institute (HCI) investigator and participates in HCI's Cancer, Cell Response and Regulation group (CCR), the breast treatment planning conference, and the Women's Disease Oriented Team (WDOT). Dr. Factor is certified by the American Board of Pathology.

Dr. Factor's research focus is in breast pathology and cytopathology. She collaborates with basic scientists, clinicians, and epidemiologists on a range of studies from the molecular basis of breast cancer to improvements in imaging modalities for screening and treatment. Dr. Factor enjoys mentoring residents and fellows, and has seen many successfully present research at national meetings.

Dr. Factor completed her medical degree at the Albert Einstein College of Medicine in the Bronx, NY, followed by residency and fellowships at Brigham and Women's Hospital in Boston, MA.

 &
Phoebe E. Freer, MD

Phoebe E. Freer, MD

Associate Professor Radiology and Imaging Sciences (Clinical), University of Utah School of Medicine

Dr. Freer serves as the Chief of the Breast Imaging section in the Department of Radiology and Imaging Sciences. She is a radiologist,and leading expert in breast imaging. She has written numerous scientific and educational publications and book chapters, many focused on breast density, breast cancer screening, and digital breast tomosynthesis. She has lectured extensively both nationally and internationally, and has trained over 2800 radiologists on the use of tomosynthesis clinically. She is a strong advocate for breast cancer screening and is a Breast Cancer Screening Leader with the American College of Radiology. In addition to her work on breast cancer screening, tomosynthesis, and breast density, Dr. Freer is a clinical expert in breast cancer imaging and procedures including mammography, ultrasound, tomosynthesis, MRI, percutaneous biopsies( including stereotactic, ultrasound, and MRI biopsies), and needle-wire or radioactive seed localizations. She strives to provide compassionate, empathetic, efficient, and accurate care to decrease patient anxiety. She recently relocated to Utah from Boston where she had served on faculty at Massachusetts General Hospital / Harvard Medical School for 7 years.

Diagnostic Challenges in Breast Pathology: the Critical Role of Radiology and Pathology Collaboration
6:30-7:30pm
Jane M. Porretta, MD, FACS

Jane M. Porretta, MD, FACS

Assistant Professor of Surgery (Clinical), University of Utah School of Medicine

Dr. Porretta is a board certified general surgeon specializing in breast surgery. She received her medical degree from Wayne State University in Detroit, MI and surgical training at the University of Utah School of Medicine. She is a fellow of the American College of Surgeons and is an active member of the American Society of Breast Surgeons.

Dr. Porretta's focus is on the surgical treatment and diagnosis of breast cancer. She served as medical director of a community breast center before joining the Huntsman Cancer Institute breast cancer team. She practices techniques in breast cancer surgery for improved cosmetic outcomes including oncoplastic procedures in breast conservation and nipple and skin sparing mastectomies. She has additional training and certification in breast ultrasound and uses this in the clinic and operating room for diagnostic assistance and improved tumor localization. She routinely uses genetic testing in her practice and has been a proponent of genomic tumor profiling to guide more personalized breast cancer treatment.

Since joining the University of Utah and the Huntsman Breast Surgery Group Dr. Porretta has expanded the surgery program in the South Jordan and Farmington Health Center facilities making access to advanced clinical care available to patients living in these communities. Dr. Porretta has been instrumental in bringing new techniques and technologies in breast surgery to the University of Utah/Huntsman facilities. She has supported clinical research enrolling patients in appropriate clinical trials from all Huntsman clinical locations.

Though Dr. Porretta has a special interest in breast surgery, she has extensive experience in general surgery practice. She has been operating for over 25 years performing laparoscopic and open surgical procedures including gallbladder surgery, hernia repair, abdominal procedures, subcutaneous and soft tissue mass excision and lymph node surgery.

Focused Updates in the Surgical Management of Breast Cancer
Tuesday, February 11
7:00-8:00am
Benjamin L. Witt, MD

Benjamin L. Witt, MD

Associate Professor of Anatomic Pathology (Clinical), University of Utah School of Medicine
Medical Director, Anatomic Pathology and Section Head, Cytopathology, ARUP Laboratories

Dr. Witt is an associate professor of anatomic pathology at the University of Utah School of Medicine, where he serves as the Director of Cytopathology, the Section Head of Head and Neck pathology, as well as the residency rotation director for Cytopathology. Dr. Witt received his MD at the University of Colorado Denver, School of Medicine and completed his AP/CP pathology residency at the University of Chicago (NorthShore) where he served as the chief resident during his last two years. He also completed a cytopathology fellowship at the University of Utah/ARUP Laboratories, and is board certified in anatomic and clinical pathology, with subspecialty boards in cytopathology. His research interests include studies related to fine-needle aspiration and head and neck pathology.

FNA/Core Biopsy of Soft Tissue: Let the Category be your Guide
8:00-9:00am
Michael B. Ward, MD

Michael B. Ward, MD

Assistant Professor of Pathology (Clinical), University of Utah School of Medicine
Medical Director, Anatomic Pathology, ARUP Laboratories

Dr. Ward is an assistant professor of anatomic pathology at the University of Utah School of Medicine. He received his undergraduate education at Brigham Young University and his medical education from the University of Texas School of Medicine. He completed his residency in Anatomic and Clinical Pathology as well as fellowships in surgical pathology and cytopathology at the University of Utah and ARUP Laboratories. Dr. Ward’s professional interests include cytology, bone and soft tissue pathology, and resident and undergraduate medical education. His research interests include translocation associated soft tissue sarcomas, and PD-L1 expression in upper-tract urothelial carcinomas.

FNA/Core Biopsy of Spindle Cell Neoplasms: Snakes or Worms?
4:30-5:30pm
Jeffrey F. Krane, MD, PhD

Jeffrey F. Krane, MD, PhD

Professor of Pathology, David Geffen School of Medicine at UCLA

Dr. Krane joined the David Geffen School of Medicine at UCLA in June 2019 as a Professor of Pathology & Laboratory Medicine and the Director of the Cytopathology fellowship program. Previously, he was at Harvard Medical School and Brigham and Women’s Hospital in Boston for 26 years where he served as the Associate Director of Cytology and the Chief of Head and Neck Pathology. Dr. Krane has broad interests in neoplasia of the head and neck region. Particular areas of research interest are in salivary gland and thyroid cytopathology and HPV-associated malignancy of the head and neck region. Dr. Krane is a former member of the Executive Board of the American Society of Cytopathology and is currently an Associate Editor of Cancer Cytopathology. He has co-authored/contributed to several books including The Bethesda System for Reporting Thyroid Cytopathology and The Milan System for Reporting Salivary Gland Cytopathology.

Update on Surgical Pathology of Head and Neck Tumors
5:30-6:30pm
Jeffrey F. Krane, MD, PhD

Jeffrey F. Krane, MD, PhD

Professor of Pathology, David Geffen School of Medicine at UCLA

Dr. Krane joined the David Geffen School of Medicine at UCLA in June 2019 as a Professor of Pathology & Laboratory Medicine and the Director of the Cytopathology fellowship program. Previously, he was at Harvard Medical School and Brigham and Women’s Hospital in Boston for 26 years where he served as the Associate Director of Cytology and the Chief of Head and Neck Pathology. Dr. Krane has broad interests in neoplasia of the head and neck region. Particular areas of research interest are in salivary gland and thyroid cytopathology and HPV-associated malignancy of the head and neck region. Dr. Krane is a former member of the Executive Board of the American Society of Cytopathology and is currently an Associate Editor of Cancer Cytopathology. He has co-authored/contributed to several books including The Bethesda System for Reporting Thyroid Cytopathology and The Milan System for Reporting Salivary Gland Cytopathology.

Milan System for Salivary Gland FNA
6:30-7:30pm
Lesley C. Lomo, MD

Lesley C. Lomo, MD

Associate Professor of Pathology (Clinical), University of Utah School of Medicine
Medical Director, Anatomic Pathology, ARUP Laboratories

Dr. Lomo is an associate professor of pathology at the University of Utah School of Medicine. She received her medical degree from Wayne State University School of Medicine in Detroit and completed her residency in anatomic and clinical pathology, as well as fellowships in women’s and perinatal pathology, breast pathology, and cytopathology at Brigham and Women’s Hospital in Boston. Dr. Lomo is board certified in anatomic and clinical pathology and cytopathology. She is a member of several professional organizations, including the United States and Canadian Academy of Pathology, the American Society for Clinical Pathology, and the International Society of Gynecological Pathologists. Her research interests include education techniques for pathology trainees and medical students, neoplastic and non-neoplastic endometrial pathology, and biomarkers of malignancy risk in preneoplastic epithelial breast disease.

Fine Needle Aspiration vs. Touch Preparation Cytology: Insights from Selected Case Presentations
Wednesday, February 12
7:00-8:00am
Jeffrey F. Krane, MD, PhD

Jeffrey F. Krane, MD, PhD

Professor of Pathology, David Geffen School of Medicine at UCLA

Dr. Krane joined the David Geffen School of Medicine at UCLA in June 2019 as a Professor of Pathology & Laboratory Medicine and the Director of the Cytopathology fellowship program. Previously, he was at Harvard Medical School and Brigham and Women’s Hospital in Boston for 26 years where he served as the Associate Director of Cytology and the Chief of Head and Neck Pathology. Dr. Krane has broad interests in neoplasia of the head and neck region. Particular areas of research interest are in salivary gland and thyroid cytopathology and HPV-associated malignancy of the head and neck region. Dr. Krane is a former member of the Executive Board of the American Society of Cytopathology and is currently an Associate Editor of Cancer Cytopathology. He has co-authored/contributed to several books including The Bethesda System for Reporting Thyroid Cytopathology and The Milan System for Reporting Salivary Gland Cytopathology.

FNA of Basaloid Neoplasms of the Head and Neck: A Case-Based Approach
8:00-9:00am
Jeffrey F. Krane, MD, PhD

Jeffrey F. Krane, MD, PhD

Professor of Pathology, David Geffen School of Medicine at UCLA

Dr. Krane joined the David Geffen School of Medicine at UCLA in June 2019 as a Professor of Pathology & Laboratory Medicine and the Director of the Cytopathology fellowship program. Previously, he was at Harvard Medical School and Brigham and Women’s Hospital in Boston for 26 years where he served as the Associate Director of Cytology and the Chief of Head and Neck Pathology. Dr. Krane has broad interests in neoplasia of the head and neck region. Particular areas of research interest are in salivary gland and thyroid cytopathology and HPV-associated malignancy of the head and neck region. Dr. Krane is a former member of the Executive Board of the American Society of Cytopathology and is currently an Associate Editor of Cancer Cytopathology. He has co-authored/contributed to several books including The Bethesda System for Reporting Thyroid Cytopathology and The Milan System for Reporting Salivary Gland Cytopathology.

NIFTP and the Updated Bethesda System for Thyroid FNA
4:30-5:30pm
Luke O. Buchmann, MD

Luke O. Buchmann, MD

Associate Professor of Surgery, University of Utah School of Medicine

Dr. Buchmann joined the Division of Otolaryngology – Head & Neck Surgery at the University of Utah in 2008. He completed his residency at the University of Kansas, and a fellowship in Head & Neck Surgery and Microvascular Reconstruction at the Medical University of South Carolina. Dr. Buchmann has published in numerous medical journals and serves on a national committee related to head and neck cancer. Dr. Buchmann's clinical practice involves the diagnosis and surgical management of head and neck neoplasms including those of the upper aerodigestive tract, salivary glands, thyroid and the neck. He has additional expertise in microvascular reconstruction following head and neck cancer surgery. Research interests include evaluating functional outcomes following head and neck cancer surgery including swallowing, quality of life outcomes, and the evaluation of patient levels of psychological distress surrounding their cancer diagnosis.

Recent Updates in the Clinical Management of Head and Neck Cancer
5:30-6:30pm
Georgios Deftereos, MD

Georgios Deftereos, MD

Assistant Professor of Pathology (Clinical), University of Utah School of Medicine
Section Head and Medical Director, Molecular Oncology, ARUP Laboratories

Dr. Deftereos is an assistant professor of pathology at the University of Utah School of Medicine. He received his MD from the University of Bari Aldo Moro in Italy. Prior to his pathology training, Dr. Deftereos completed a research fellowship focusing on HPV and gynecological malignancies at the University of Washington. He then completed a residency in anatomic and clinical pathology at Pittsburgh's Allegheny General Hospital, followed by consecutive clinical fellowships in cytopathology and molecular genetic pathology at the University of Washington. Dr. Deftereos is board certified in anatomic pathology, clinical pathology, cytopathology, and molecular genetic pathology, and provides service in the areas of molecular oncology and cytopathology. His research interests include epigenetics of solid tumors and minimally invasive precision diagnostics, with emphasis on the use of molecular testing in cytopathology of solid tumors.

Molecular Diagnostics in Cytology and Small Biopsy Specimens of Non-Small Cell Lung Cancer
6:30-7:30pm
Marc Barry, MD

Marc Barry, MD

Non-neoplastic Kidney Pathology for the General Surgical Pathologist
Thursday, February 13
7:00-8:00am
Anton Rets, MD, PHD

Anton Rets, MD, PHD

Assistant Professor of Pathology (Clinical), University of Utah School of Medicine
Medical Director, ARUP Laboratories

Dr. Rets is an assistant professor of pathology at the University of Utah School of Medicine. He received his MD and PhD at Perm State Academy of Medicine in Russia. He served as an anatomical and clinical pathology resident at State University of New York Health Science Center at Brooklyn and a hematopathology fellow at the University of Utah School of Medicine. Dr. Rets is board certified in hematopathology, anatomic pathology, and clinical pathology. He is also a member of several professional societies, including the College of American Pathologists and the American Society for Clinical Pathology. Dr. Rets’ professional interests include red blood cell disorders, non-neoplastic hematology, and precursor lymphoid neoplasms.

Hypocellular Bone Marrow: What’s Next?
8:00-9:00am
Rodney R. Miles, MD, PhD

Rodney R. Miles, MD, PhD

Associate Professor of Pathology, University of Utah School of Medicine
Section Chief, Hematopathology; Medical Director, Hematologic Flow Cytometry; Medical Director, Immunohistochemistry Laboratory; Medical Director, Histology Laboratory, ARUP Laboratories

Dr. Miles is the Section Chief of Hematopathology at ARUP Laboratories and an associate professor of pathology at the University of Utah School of Medicine. Dr. Miles received his MD and a PhD in cell biology from the University of Nebraska. He is certified by the American Board of Pathology in anatomic and clinical pathology, with subspecialty certification in hematology. His research interests include pediatric non-Hodgkin lymphoma and acute lymphoblastic leukemia.

Dr. Miles is a member of the American Society of Hematology, the Society for Hematopathology, and the United States and Canadian Academy of Pathology. He is a member of the Children's Oncology Group non-Hodgkin lymphoma committee and serves as a central pathology reviewer for clinical trials.

Ancillary Testing in Lymphoma Diagnosis and the Challenges of Small Biopsies
9:00-10:00am
Jamie Zussman, MD

Jamie Zussman, MD

Assistant Professor of Dermatology (Clinical), University of Utah School of Medicine

Dr. Zussman is a practicing Dermatologist in Salt Lake City, UT. Dr. Zussman graduated from University of California Los Angeles David Geffen School of Medicine in 2007 and has been in practice for 11 years. She completed a residency at UCLA Medical Center. She currently practices at University of Utah School of Medicine and is affiliated with Primary Children's Medical Center. Dr. Zussman is a board certified dermatologist with a special interest in new rashes, infectious dermatology, medical dermatology, and skin cancer.

Morphologic Mimics in Dermatopathology: Diagnostic Blunders to Avoid